Medicine:Steroid eluting sinus stent
From HandWiki
Steroid-eluting sinus stents may be used in addition to endoscopic sinus surgery. They are, however, of unclear benefit as of 2015.[1] One version releases mometasone furoate. It is a bioabsorbable steroid-eluting stent. It delivers steroids over a 30-day period prior to dissolving.[2]
Society and culture
A number of brands exist including Relieva Stratus Spacer and Propel sinus implant.[3][4]
Approval
One brand received pre-market approval from the FDA in 2011.
References
- ↑ Huang, Z; Hwang, P; Sun, Y; Zhou, B (10 June 2015). "Steroid-eluting sinus stents for improving symptoms in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery.". The Cochrane Database of Systematic Reviews (6): CD010436. doi:10.1002/14651858.CD010436.pub2. PMID 26068957.
- ↑ Lee, Jivianne T; Han, Joseph K (2013). "Sinus implants for chronic rhinosinusitis: Technology evaluation". Expert Opinion on Drug Delivery 10 (12): 1735–48. doi:10.1517/17425247.2013.839654. PMID 24088141.
- ↑ Liang, Jonathan; Lane, Andrew P. (2012). "Topical Drug Delivery for Chronic Rhinosinusitis". Current Otorhinolaryngology Reports 1 (1): 51–60. doi:10.1007/s40136-012-0003-4. PMID 23525506.
- ↑ Kennedy, David W (2012). "The PROPEL™ steroid-releasing bioabsorbable implant to improve outcomes of sinus surgery". Expert Review of Respiratory Medicine 6 (5): 493–8. doi:10.1586/ers.12.53. PMID 23134241.
 |  |
